VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44 Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 1:30 p.m. PT (4:30 ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb†or the "company†), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the "Replacement Term Loans†) of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 (the "Third Amendment Term Loans†) and its outstanding term B loans due 2028 (the "First Increment ...

Company Overview - Pro-Dex, Inc. (PDEX) is a contract manufacturer focused on designing, developing, and manufacturing surgical devices for the medical device industry [1] - The stock has experienced significant volatility over the past year, trading between a high of $70 and a low of $16 [1] Performance Insights - The company has achieved record performance, although specific metrics or figures are not provided in the text [1]